BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 12940073)

  • 21. Immunohistochemical expression of the p53, mdm2, p21/Waf-1, Rb, p16, Ki67, cyclin D1, cyclin A and cyclin B1 proteins and apoptotic index in T-cell lymphomas.
    Kanavaros P; Bai M; Stefanaki K; Poussias G; Rontogianni D; Zioga E; Gorgoulis V; Agnantis NJ
    Histol Histopathol; 2001 Apr; 16(2):377-86. PubMed ID: 11332692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression of p21(WAF1) and its relationship with p53 and PCNA protein in epithelial ovarian cancer].
    Yan XJ; Liang LZ; Li DC; Li JL; Zhang CQ; Yuan SH
    Ai Zheng; 2004 Jan; 23(1):74-80. PubMed ID: 14720380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The abnormalities in the p53/p21WAF1 pathway have a significant role in the pathogenesis and progression of gastrointestinal stromal tumors.
    Chou YP; Lin JW; Wang CC; Chiu YC; Huang CC; Chuah SK; Tai MH; Yi LN; Lee CM; Changchien CS; Hu TH
    Oncol Rep; 2008 Jan; 19(1):49-56. PubMed ID: 18097575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic factors in astrocytomas: relationship of p53, MDM-2, BCL-2 and PCNA immunohistochemical expression to tumor grade and overall patient survival.
    Ehrmann J; Kolár Z; Vojtĕsek B; Kala M; Komenda S; Oulton A
    Neoplasma; 1997; 44(5):299-304. PubMed ID: 9473789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical expression of retinoblastoma gene product (Rb), p53 protein, MDM2, c-erbB-2, HLA-DR and proliferation indices in human urinary bladder carcinoma.
    Ioachim E; Charchanti A; Stavropoulos NE; Skopelitou A; Athanassiou ED; Agnantis NJ
    Histol Histopathol; 2000 Jul; 15(3):721-7. PubMed ID: 10963116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of p53, p21, mdm2, Rb, bax and Ki67 proteins in lymphomas of the mucosa-associated lymphoid (MALT) tissue.
    Stefanaki K; Tzardi M; Kouvidou C; Chaniotis V; Bolioti M; Vlychou M; Zois M; Kakolyris S; Delides G; Rontogianni D; Georgoulias V; Kanavaros P
    Anticancer Res; 1998; 18(4A):2403-8. PubMed ID: 9703886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoexpression of tumor suppressor genes p53, p21 WAF1/CIP1 and p27 KIP1 in humam astrocystic tumors.
    Faria MH; Patrocínio RM; Moraes Filho MO; Rabenhorst SH
    Arq Neuropsiquiatr; 2007 Dec; 65(4B):1114-22. PubMed ID: 18345413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expression of proteins in p53 (p14ARF-mdm2-p53-p21WAF/CIP1) pathway and their significance in exocrine pancreatic carcinoma].
    Yu GZ; Zhu MH; Ni CR; Li FM; Zheng JM; Gong ZJ
    Zhonghua Bing Li Xue Za Zhi; 2004 Apr; 33(2):130-4. PubMed ID: 15132849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RT-PCR amplification of RNA extracted from formalin-fixed, paraffin-embedded oral cancer sections: analysis of p53 pathway.
    Tachibana M; Shinagawa Y; Kawamata H; Omotehara F; Horiuchi H; Ohkura Y; Kubota K; Imai Y; Fujibayashi T; Fujimori T
    Anticancer Res; 2003; 23(3C):2891-6. PubMed ID: 12926130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proliferating cell nuclear antigen, p53 and micro vessel density: Grade II vs. Grade III astrocytoma.
    Malhan P; Husain N; Bhalla S; Gupta RK; Husain M
    Indian J Pathol Microbiol; 2010; 53(1):20-3. PubMed ID: 20090216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative evaluation of p53-protein expression and the PCNA and Ki-67 proliferating cell indices in human astrocytomas.
    Kordek R; Biernat W; Debiec-Rychter M; Alwasiak J; Liberski PP
    Pathol Res Pract; 1996 Mar; 192(3):205-9. PubMed ID: 8739466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical detection of bcl2, p53, mdm2 and p21/waf1 proteins in small-cell lung carcinomas.
    Stefanaki K; Rontogiannis D; Vamvouka C; Bolioti S; Chaniotis V; Sotsiou F; Vlychou M; Delidis G; Kakolyris S; Georgoulias V; Kanavaros P
    Anticancer Res; 1998; 18(2A):1167-73. PubMed ID: 9615783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical detection of bcl2, p53, mdm2 and p21/waf1 proteins in small-cell lung carcinomas.
    Stefanaki K; Rontogiannis D; Vamvouka C; Bolioti S; Chaniotis V; Sotsiou F; Vlychou M; Delidis G; Kakolyris S; Georgoulias V; Kanavaros P
    Anticancer Res; 1998; 18(3A):1689-95. PubMed ID: 9673391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mdm2 and the p53 pathway in human pituitary adenomas.
    Suliman M; Royds J; Cullen D; Timperley W; Powell T; Battersby R; Jones TH
    Clin Endocrinol (Oxf); 2001 Mar; 54(3):317-25. PubMed ID: 11298083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accumulation of wild-type p53 in astrocytomas is associated with increased p21 expression.
    Ono Y; Tamiya T; Ichikawa T; Matsumoto K; Furuta T; Ohmoto T; Akiyama K; Seki S; Ueki K; Louis DN
    Acta Neuropathol; 1997 Jul; 94(1):21-7. PubMed ID: 9224526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [WAF1/CIP1/p21 gene in wild type p53 and mutant p53 human breast cancer cell lines in relation to its cytobiological features].
    Jiang M; Shao Z; Wu J
    Zhonghua Zhong Liu Za Zhi; 1998 May; 20(3):181-4. PubMed ID: 10921001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p21WAF1/CIP1 and MDM2 expression in non-Hodgkin's lymphoma and their relationship to p53 status: a p53+, MDM2-, p21-immunophenotype associated with missense p53 mutations.
    Villuendas R; Pezzella F; Gatter K; Algara P; Sánchez-Beato M; Martínez P; Martínez JC; Muñoz K; García P; Sánchez L; Kocialkowsky S; Campo E; Orradre JL; Piris MA
    J Pathol; 1997 Jan; 181(1):51-61. PubMed ID: 9072003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53, Mdm2, and c-Myc overexpression is associated with a poor prognosis in aggressive non-Hodgkin's lymphomas.
    Pagnano KB; Vassallo J; Lorand-Metze I; Costa FF; Saad ST
    Am J Hematol; 2001 Jun; 67(2):84-92. PubMed ID: 11343379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival.
    Aaltomaa S; Lipponen P; Ala-Opas M; Eskelinen M; Syrjänen K; Kosma VM
    Br J Cancer; 1999 Aug; 80(12):2001-7. PubMed ID: 10471053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.